Literature DB >> 16153313

Urinary schistosomiasis on Zanzibar: application of two novel assays for the detection of excreted albumin and haemoglobin in urine.

D Rollinson1, E V Klinger, A F Mgeni, I S Khamis, J R Stothard.   

Abstract

As part of a urinary schistosomiasis control programme on Zanzibar, an aged cross-sectional survey of 305 children from three schools on Unguja was conducted to investigate the relationships between levels of excreted albumin and haemoglobin in urine and Schistosoma haematobium infection status. Diagnosis was determined by standard parasitological methods, dipstick reagents for microhaematuria, visual inspection for macrohaematuria as well as collection of case-history questionnaire data for self-diagnosis. Prevalence of infection as determined by parasitology was 53.9% and approximately, one quarter of the children examined were anaemic (<11 g dl(-1)). A statistically significant negative association of blood haemoglobin levels of boys and S. haematobium infection intensity status was observed (rs=-0.23, P=0.005). Through sensitivity analysis of urine-albumin values it was determined that a concentration of above >40 mg l(-1), as measured with the HemoCue urine-albumin photometer, had sensitivity, specificity, positive and negative predictive values of 0.90, 0.83, 0.86 and 0.89 respectively against 'gold-standard' parasitology. There was a clear association of reported pain upon micturition for children with elevated urine-albumin levels, with an odds ratio of 20 to 1. Levels of excreted blood in urine were quantified with the HemoCue Plasma/Low Hb photometer. However, dipsticks remain the method of choice for urine-haemoglobin of 0.1 g l(-1) and below. Urine parameters over a 24-h period were assessed in a small sub-sample. Reductions in both albumin and haemoglobin excretion were observed in 11 children 54 days after praziquantel treatment. It was concluded that these rapid, high-through-put, portable HemoCue assays could play a role in better describing and monitoring the occurrence, severity and evolution of urinary schistosomiasis disease. The urine-albumin assay has particular promise as a biochemical marker of S. haematobium induced kidney- and upper urinary tract-morbidity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16153313     DOI: 10.1079/joh2005305

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  16 in total

Review 1.  Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas.

Authors:  Eleanor A Ochodo; Gowri Gopalakrishna; Bea Spek; Johannes B Reitsma; Lisette van Lieshout; Katja Polman; Poppy Lamberton; Patrick M M Bossuyt; Mariska M G Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2015-03-11

2.  Epidemiology of malaria, schistosomiasis, geohelminths, anemia and malnutrition in the context of a demographic surveillance system in northern Angola.

Authors:  José Carlos Sousa-Figueiredo; Dina Gamboa; João Mário Pedro; Cláudia Fançony; António Justino Langa; Ricardo J Soares Magalhães; J Russell Stothard; Susana Vaz Nery
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

3.  Identifying and evaluating field indicators of urogenital schistosomiasis-related morbidity in preschool-aged children.

Authors:  Welcome M Wami; Norman Nausch; Nicholas Midzi; Reggis Gwisai; Takafira Mduluza; Mark Woolhouse; Francisca Mutapi
Journal:  PLoS Negl Trop Dis       Date:  2015-03-20

4.  Measuring morbidity associated with urinary schistosomiasis: assessing levels of excreted urine albumin and urinary tract pathologies.

Authors:  José C Sousa-Figueiredo; María-Gloria Basáñez; I Simba Khamis; Amadou Garba; David Rollinson; J Russell Stothard
Journal:  PLoS Negl Trop Dis       Date:  2009-10-06

5.  A comparison of urinary tract pathology and morbidity in adult populations from endemic and non-endemic zones for urinary schistosomiasis on Unguja Island, Zanzibar.

Authors:  Beatrice Lyons; Russel Stothard; David Rollinson; Simba Khamis; Khamis A Simai; Paul R Hunter
Journal:  BMC Infect Dis       Date:  2009-11-29       Impact factor: 3.090

6.  Dynamics of Schistosoma haematobium egg output and associated infection parameters following treatment with praziquantel in school-aged children.

Authors:  Katarina Stete; Stefanie J Krauth; Jean T Coulibaly; Stefanie Knopp; Jan Hattendorf; Ivan Müller; Laurent K Lohourignon; Winfried V Kern; Eliézer K N'goran; Jürg Utzinger
Journal:  Parasit Vectors       Date:  2012-12-21       Impact factor: 3.876

Review 7.  Epidemiology and control of human schistosomiasis in Tanzania.

Authors:  Humphrey D Mazigo; Fred Nuwaha; Safari M Kinung'hi; Domenica Morona; Angela Pinot de Moira; Shona Wilson; Jorg Heukelbach; David W Dunne
Journal:  Parasit Vectors       Date:  2012-11-28       Impact factor: 3.876

8.  Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach.

Authors:  Stefanie Knopp; Khalfan A Mohammed; Said M Ali; I Simba Khamis; Shaali M Ame; Marco Albonico; Anouk Gouvras; Alan Fenwick; Lorenzo Savioli; Daniel G Colley; Jürg Utzinger; Bobbie Person; David Rollinson
Journal:  BMC Public Health       Date:  2012-10-30       Impact factor: 3.295

9.  Elimination of schistosomiasis transmission in Zanzibar: baseline findings before the onset of a randomized intervention trial.

Authors:  Stefanie Knopp; Bobbie Person; Shaali M Ame; Khalfan A Mohammed; Said M Ali; I Simba Khamis; Muriel Rabone; Fiona Allan; Anouk Gouvras; Lynsey Blair; Alan Fenwick; Jürg Utzinger; David Rollinson
Journal:  PLoS Negl Trop Dis       Date:  2013-10-17

10.  Schistosomiasis in pre-school-age children and their mothers in Chikhwawa district, Malawi with notes on characterization of schistosomes and snails.

Authors:  Helen Poole; Dianne J Terlouw; Andrew Naunje; Kondwani Mzembe; Michelle Stanton; Martha Betson; David G Lalloo; J Russell Stothard
Journal:  Parasit Vectors       Date:  2014-04-01       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.